Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
1226
CALL
DELISTED
bluebird bio
BLUE
| $16M | 0.01% |
6,948
+556
| +9% | +$1.13M |
|
1227
Roku
ROKU
$23.3B
| $16M | 0.01% |
309,559
+267,256
| +632% | +$9.2M |
|
1228
PUT
Direxion Daily Gold Miners Index Bull 2X ETF
NUGT
$1.23B
| $16M | 0.01% |
100,920
-48,480
| -32% | -$7.29M |
|
1229
Trip.com Group
TCOM
$28.3B
| $16M | 0.01% |
+361,796
| New | +$17.3M |
|
|
SINA
1230
CALL
DELISTED
Sina Corp
SINA
| $15.9M | 0.01% |
159,000
-19,500
| -11% | -$2.08M |
|
|
SINA
1231
DELISTED
Sina Corp
SINA
| $15.9M | 0.01% |
+158,970
| New | +$17M |
|
1232
Tyler Technologies
TYL
$13.5B
| $15.9M | 0.01% |
+89,809
| New | +$15.9M |
|
1233
Collegium Pharmaceutical
COLL
$896M
| $15.9M | 0.01% |
860,727
+316,694
| +58% | +$4.54M |
|
|
BLUE
1234
PUT
DELISTED
bluebird bio
BLUE
| $15.9M | 0.01% |
6,886
+1,111
| +19% | +$2.26M |
|
1235
PUT
Direxion Daily Financial Bull 3x ETF
FAS
$2.49B
| $15.9M | 0.01% |
232,200
+91,600
| +65% | +$5.72M |
|
|
JOYY
1236
JOYY Inc
JOYY
$3.67B
| $15.8M | 0.01% |
140,194
+42,167
| +43% | +$4.23M |
|
1237
CALL
Charter Communications
CHTR
$18.6B
| $15.8M | 0.01% |
47,000
+500
| +1% | +$170K |
|
1238
Rigel Pharmaceuticals
RIGL
$790M
| $15.8M | 0.01% |
406,954
+387,140
| +1,954% | +$14.7M |
|
1239
Empire State Realty Trust
ESRT
$829M
| $15.8M | 0.01% |
768,730
-402,146
| -34% | -$8.23M |
|
|
1240
CALL
Roku
ROKU
$23.3B
| $15.8M | 0.01% |
+304,700
| New | +$10.5M |
|
1241
Hilton Grand Vacations
HGV
$3.53B
| $15.7M | 0.01% |
373,954
+345,365
| +1,208% | +$14M |
|
|
JNPR
1242
CALL
DELISTED
Juniper Networks
JNPR
| $15.7M | 0.01% |
549,300
+343,000
| +166% | +$9.27M |
|
1243
PUT
Estee Lauder
EL
$31.5B
| $15.7M | 0.01% |
123,000
+22,800
| +23% | +$2.74M |
|
1244
IQVIA
IQV
$39.5B
| $15.6M | 0.01% |
159,697
+52,481
| +49% | +$5.34M |
|
1245
CALL
BP
BP
$110B
| $15.6M | 0.01% |
406,061
-863,040
| -68% | -$31.3M |
|
1246
PUT
Rio Tinto
RIO
$157B
| $15.6M | 0.01% |
295,100
+32,800
| +13% | +$1.6M |
|
1247
Agree Realty
ADC
$9.36B
| $15.6M | 0.01% |
303,503
+89,744
| +42% | +$4.45M |
|
1248
Coherus Oncology
CHRS
$178M
| $15.6M | 0.01% |
1,772,241
+1,579,582
| +820% | +$16.9M |
|
1249
CALL
Under Armour
UAA
$2.31B
| $15.6M | 0.01% |
1,079,000
+367,200
| +52% | +$5.31M |
|
|
JWN
1250
CALL
DELISTED
Nordstrom
JWN
| $15.5M | 0.01% |
327,200
-111,600
| -25% | -$4.81M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.